Product Images Labetalol Hcl

This is a label for a multi-dose vial of Labetalol injection, which is a medication used for intravenous injection to treat high blood pressure. The vial contains 100 mg of the medication in 20 mL of solution, at a concentration of 5 mg/mL. The label indicates that it is only for intravenous injection and is sterile. Manufacturer is Westward.*

This appears to be a chart or table showing the frequency of certain symptoms experienced by individuals taking a medication called ETEE at a 200mg dose. The symptoms listed include nausea, vomiting, fatigue, dyspepsia, paresthesia, and edema, among others. The chart also lists the number of individuals reporting each symptom in 9 different categories, labeled DDZ, Heimd, and numbers 52, 181, 606, 608, 503, 117, 242, and 175.*

This is a label of a medication called Labetalol HCI Injection. It is a sterile solution for intravenous injection only, and should not be frozen. It comes in a 20 mL multiple dose vial, and the usual dosage should be determined by a physician. The solution contains labetalol hydrochloride, methylparaben, and propylparaben as preservatives. The medication is distributed by HIKMA PHARMACEUTICALS and is Rxonly. The label includes the NDC numbers and storage instructions.*

This text provides instructions for inpatient titration with four different regimens ranging from 200 mg b.i.d. to 1,200 mq b.i.d., with corresponding daily doses ranging from 400 mg to 2,400 mg. It also notes that if necessary, the total daily dose can be divided into three separate doses.*

This is the product information for the drug "Labetalol Injection, USP". It is a clear, colorless solution for intravenous administration, with a concentration of 5 mg/mL. It is intended for intravenous use only.*